Michael Shelanski

PurpleSun, Inc. is a technology company that designs and manufactures hospital-grade ultraviolet light delivery systems for the purpose of disinfecting critical equipment and rooms with the highest efficacy and fastest speed. The private company is based in Long Island City, NY. PurpleSun is partnered with some of the largest healthcare systems and aims to become the world's leading brand in sustainable infection prevention solutions for patients, staff, and hospitals. The company's solutions allow for hospital-wide application, with one of the only products not requiring evacuation of the room during use. The company was founded in 2012 by Audrey McNicholas, Luis F. Romo, Wladyslaw Kowalski. David Lawrence Eigen has been the CEO of the company since 2021.

Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts.

Ares Secondaries Group (Ares Secondaries) is a private equity subsidiary of Ares Holdings LP founded in 1989 by Brent R.Nicklas. The firm is headquartered in Simsbury, Connecticut.

Lawrence Berkeley National Laboratory engages on research of environmental studies, nanoscience, and quantitative biology, physics and nuclear energy. The lab is funded by the U.S. Department of Energy and managed by the University of California. It was founded in 1931 by Ernest Orlando Lawrence and is headquartered in Berkeley, CA.

SelectX Pharmaceuticals, Inc. engages in the discovery and development of aminoglycoside therapeutics for unmet medical needs. Its advanced program, development candidate SXP2523, is a next generation aminoglycoside antibiotic for drug resistant gram-negative hospital-acquired infections (HAIs); SXP2523 possesses broad spectrum coverage with potency against Pseudomonas, Klebsiella, Acinetobacter, E. coli, and Staphylococcus. The company was founded by Michael G. Chaparian and Charles R. Cantor in 2002 and is headquartered in Boston, MA.

National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC.

The Human BioMolecular Research Institute is a research organization that focuses on advancing scientific knowledge in the fields of biochemistry, molecular biology, and biophysics. The non-profit company is based in San Diego, CA. The institute conducts research on a wide range of topics, including cancer, infectious diseases, and neurodegenerative disorders. The company's goal is to develop new treatments and therapies that can improve human health and well-being.

Retrotope, Inc. operates as clinical-stage pharmaceutical company that develops drugs to treat degenerative diseases. It offers drugs and therapies to treat Parkinson’s, Alzheimer’s, mitochondrial myopathies and retinopathies diseases. The company was founded by Charles R. Cantor, Robert J. Molinari, and Mikhail S. Shchepinov in 2006 and is headquartered in Los Altos, CA.

Northwell Holdings is a venture capital subsidiary of Northwell Health, Inc. founded in 2013. The firm is headquartered in New York.

Accelerate Long Island/venture capital/ (Accelerate Long Island (Venture Capital)) is a venture capital subsidiary of Accelerate Long Island, Inc founded in 2016. The firm is headquartered in Melville, New York.